Pulse Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. on May 20, 2021. The report details the results of the Company's 2021 Annual Meeting of Stockholders, which was conducted as a virtual meeting via live audio webcast on the same date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders voted on two primary proposals:
- Election of Directors: Seven nominees were elected to serve until the 2022 Annual Meeting. All nominees received significant majority support, with "For" votes ranging from approximately 16.2 million to 17.6 million. Broker non-votes totaled 4,707,588 for each director nominee.
- Ratification of Auditors: Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021. The proposal received 22,371,040 votes "For" and 6,788 votes "Against."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the procedural reporting of the Annual Meeting outcomes.
Key Facts for Investor Verification
- Confirmation that all seven director nominees were successfully elected.
- Verification of the ratification of Deloitte & Touche LLP as the independent auditor.
- Review of the specific vote counts to assess the level of shareholder support for the board and management.